Product image of Macrogol Milpharm (Macrogol 4000) supplied by GNH India

Macrogol Milpharm

Active Ingredient:
Macrogol 4000
Origin:
EU

Macrogol Milpharm (Macrogol 4000)

Macrogol 4000, the active ingredient in Macrogol Milpharm, is an osmotic laxative presented as an oral formulation for oral use. It is used to relieve constipation by softening stool and facilitating bowel movements in adults and children when appropriate.

GNH India supplies Macrogol Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Milpharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Macrogol Milpharm is an osmotic laxative that acts on the gastrointestinal tract to treat constipation.

  • Constipation: softens stool and promotes regular bowel movements in patients experiencing infrequent or difficult defecation.

How It Works

  • Macrogol 4000 functions as an osmotic agent that is poorly absorbed in the gastrointestinal lumen. By retaining water within the intestinal contents, it increases stool volume and softness, which stimulates peristalsis and facilitates the passage of feces without directly affecting intestinal motility receptors.

Side Effects

Macrogol Milpharm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Abdominal bloating: sensation of fullness or swelling in the abdomen.
  • Flatulence: increased intestinal gas production.
  • Nausea: mild feeling of queasiness.
  • Mild abdominal cramps: intermittent discomfort.
  • Diarrhoea: loose stools occurring more frequently.
  • Thirst: increased desire to drink fluids.

Serious or Rare Side Effects

  • Electrolyte imbalance: abnormal levels of sodium, potassium, or other electrolytes.
  • Severe dehydration: marked loss of body fluids.
  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Intestinal obstruction: worsening constipation or blockage.
  • Severe abdominal pain: persistent, intense discomfort.
  • Blood in stool: visible bleeding from the gastrointestinal tract.

Precautions & Warnings

Before using Macrogol Milpharm, consider the following safety measures.

  • Hydration assessment: ensure adequate fluid intake to prevent dehydration.
  • Medical history review: disclose any gastrointestinal disorders, such as bowel obstruction or inflammatory disease.
  • Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance.
  • Concomitant laxatives: avoid using other osmotic or stimulant laxatives simultaneously.
  • Renal impairment caution: adjust use in patients with reduced kidney function.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Macrogol Milpharm can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Other osmotic laxatives: combined use may cause excessive fluid loss and electrolyte disturbances.
  • Loop diuretics: increased risk of dehydration and electrolyte imbalance.

Moderate Interactions (Monitor Closely)

  • Antacids containing magnesium or aluminum: may reduce the efficacy of macrogol.
  • Oral iron supplements: can alter absorption and increase gastrointestinal irritation.
  • Certain antibiotics (e.g., tetracyclines): may have reduced absorption when taken with macrogol.
  • Antihypertensive agents: monitor blood pressure if dehydration occurs.

Frequently Asked Questions

Macrogol Milpharm is used to relieve occasional or chronic constipation. The macrogol 4000 component acts as an osmotic laxative, drawing water into the intestinal lumen to soften stool and promote regular bowel movements in adults and children as directed by a healthcare professional.

Macrogol 4000 works by retaining water within the gastrointestinal tract because it is poorly absorbed. This osmotic effect increases stool water content, making the stool softer and bulkier, which stimulates peristalsis and facilitates easier passage without directly stimulating intestinal muscles.

The appropriate dose of Macrogol Milpharm is determined by the prescribing clinician based on the patient’s age, weight, severity of constipation, and response to therapy. Patients should follow the specific instructions provided by their healthcare professional and the product label.

Safety data for Macrogol Milpharm in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To order Macrogol Milpharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with stimulant laxatives, macrogol 4000 provides a gentler, osmotic mechanism that softens stool without causing cramping. It is often preferred for long‑term management of constipation because it has a lower risk of dependence and fewer systemic side effects than stimulant agents.

Macrogol Milpharm should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Macrogol Milpharm is taken orally, usually dissolved in a measured amount of water or another suitable liquid as directed by the prescriber. The solution should be consumed promptly after preparation to ensure optimal efficacy.

Serious risks, though rare, include severe dehydration, electrolyte disturbances (especially sodium and potassium), allergic reactions such as rash or anaphylaxis, and worsening of intestinal obstruction. Patients should seek medical attention if they experience severe abdominal pain, persistent diarrhoea, or signs of an allergic response.

Macrogol Milpharm should be avoided in individuals with known hypersensitivity to macrogol or any excipients, those with complete intestinal obstruction, severe inflammatory bowel disease, or acute abdominal conditions. It should also be used with caution in patients with renal impairment or electrolyte disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Macrogol 4000

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT